Implementation science in times of Covid-19.


Journal

Implementation science : IS
ISSN: 1748-5908
Titre abrégé: Implement Sci
Pays: England
ID NLM: 101258411

Informations de publication

Date de publication:
08 06 2020
Historique:
entrez: 10 6 2020
pubmed: 10 6 2020
medline: 7 7 2020
Statut: epublish

Résumé

The emergence of SARS-CoV-2/Covid-19 affects all of us and is associated with rapid and massive changes in healthcare and societies. As a response, a range of interventions for patients and populations have been implemented in health and preventive settings, or need to be implemented in the short and long term. Implementation science offers a multidisciplinary perspective and systematic approach for the design, evaluation and analysis of programmes and policies to enhance implementation. The emergence of Covid-19 provides an urgent need to develop new perspectives and approaches in implementation science, such as the addition of innovative and rigorous approaches to the collection, use and analysis of 'real-world' data. Above all, we hope that implementation scientists will focus on what they can contribute to manage Covid-19 and its consequences for people, healthcare and society.

Identifiants

pubmed: 32513292
doi: 10.1186/s13012-020-01006-x
pii: 10.1186/s13012-020-01006-x
pmc: PMC7276954
doi:

Types de publication

Editorial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

42

Références

Implement Sci. 2008 Nov 13;3:49
pubmed: 19014512
Nature. 2020 May;581(7807):130-131
pubmed: 32382120
Implement Sci. 2019 Mar 27;14(1):34
pubmed: 30917844
Clin Med (Lond). 2019 Jan;19(1):47-56
pubmed: 30651245
Syst Rev. 2015 Apr 17;4:50
pubmed: 25925676
Implement Sci. 2016 Oct 26;11(1):146
pubmed: 27782832
Lancet Public Health. 2020 May;5(5):e240
pubmed: 32247329
BMJ. 2020 May 12;369:m1847
pubmed: 32398241
BMJ. 2020 May 15;369:m1932
pubmed: 32414712
Nat Hum Behav. 2020 May;4(5):451-459
pubmed: 32377018
Bull World Health Organ. 2012 May 1;90(5):357-64
pubmed: 22589569
J Med Internet Res. 2017 Nov 01;19(11):e367
pubmed: 29092808
Implement Sci. 2019 Jun 6;14(1):57
pubmed: 31171004

Auteurs

Michel Wensing (M)

Department of General Practice and Health Services Research, University Hospital Heidelberg, Heidelberg, Germany. Michel.Wensing@med.uni-heidelberg.de.
Faculty of Medicine, University of Heidelberg, Heidelberg, Germany. Michel.Wensing@med.uni-heidelberg.de.

Anne Sales (A)

Department of Veteran Affairs Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.
Department of Learning Health Sciences, University of Michigan Medical School, Ann Arbor, MI, USA.

Rebecca Armstrong (R)

National Disability Insurance Agency, Melbourne, Australia.

Paul Wilson (P)

University of Manchester, Manchester, UK.
NIHR Applied Research Collaboration Greater Manchester, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH